# A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma

> clinical trial · VERIFIED · 2026-08-10

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Non-Hodgkin Lymphoma

- Company: Hoffmann-La Roche
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05169515

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.